Barclays Remains a Buy on Sabre Insurance Group plc (SBRE)
Barclays' Ivan Bokhmat reiterated a Buy rating on Sabre Insurance Group (SBRE) with a £1.96 price target. The company reported Q2 revenue of £112.12M and net profit of £17.94M, up from £50.95M and £9.46M respectively last year. Analyst consensus is Moderate Buy with a £1.91 price target. Insider sentiment is negative.
How this was made

The 30-second read
Why it matters
The new Buy rating and price target may attract short‑term buying, but insider sell‑off could limit gains.
Market read
Analyst upgrade provides a fresh catalyst for SBRE.L; investors should weigh against negative insider sentiment.
What to watch
Potential macro‑economic headwinds for insurers could temper upside.
Background
Barclays analyst coverage includes peers in the UK insurance market; the rating aligns with sector optimism.
Market effects
Positive signal for UK insurance sector, may boost peers like Aviva and Hiscox.
Supports broader UK market sentiment in financial services.
Limited to UK insurers; minimal global impact.
Counterpoint
Insider selling sentiment is negative, suggesting caution despite the upgrade.
Key entities
- companySabre Insurance Group plc
UK‑listed insurer receiving a Buy rating from Barclays.
- analystIvan Bokhmat
Barclays analyst covering the financial sector.



